Shandong Qidu Pharmaceutical Co. Ltd., commonly referred to as Qidu Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shandong, China. Established in 2001, the company has rapidly expanded its operations across various regions, focusing on the development and manufacturing of high-quality pharmaceutical products. Qidu Pharma specialises in a diverse range of therapeutic areas, including cardiovascular, anti-infective, and oncology medications. Their commitment to innovation is evident in their unique formulations and advanced manufacturing processes, which adhere to stringent quality standards. With a strong market presence, Qidu Pharma has achieved significant milestones, including numerous certifications and partnerships that enhance its reputation in the global pharmaceutical landscape. The company continues to strive for excellence, positioning itself as a trusted provider of effective healthcare solutions.
How does Shandong Qidu Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shandong Qidu Pharmaceutical Co. Ltd's score of 20 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shandong Qidu Pharmaceutical Co. Ltd, headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. Given the absence of emissions data and reduction initiatives, it is unclear how Shandong Qidu Pharmaceutical aligns with industry standards for climate action. The pharmaceutical sector is increasingly focusing on sustainability and carbon neutrality, and companies are encouraged to adopt science-based targets to mitigate their environmental impact. However, without specific commitments or data, it is challenging to assess Shandong Qidu's position within this context.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shandong Qidu Pharmaceutical Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.